Sol J Barer - Net Worth and Insider Trading
Sol J Barer Net Worth
The estimated net worth of Sol J Barer is at least $167 Million dollars as of 2024-05-05. Sol J Barer is the Director of Celgene Corp and owns about 1,506,946 shares of Celgene Corp (CELG) stock worth over $163 Million. Sol J Barer is the Director of Teva Pharmaceutical Industries Ltd and owns about 220,442 shares of Teva Pharmaceutical Industries Ltd (TEVA) stock worth over $3 Million. Sol J Barer is also the Director of NexImmune Inc and owns about 164,096 shares of NexImmune Inc (NEXI) stock worth over $544,799. Besides these, Sol J Barer also holds Amicus Therapeutics Inc (FOLD) , PDS Biotechnology Corp (PDSB) , ContraFect Corp (CFRXQ) , Aevi Genomic Medicine Inc (GNMX) . Details can be seen in Sol J Barer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sol J Barer has not made any transactions after 2023-03-30 and currently still holds the listed stock(s).
Transaction Summary of Sol J Barer
Sol J Barer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sol J Barer owns 10 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) , Avalo Therapeutics Inc (AVTX) , and ContraFect Corp (CFRXQ) among others .
Click here to see the complete history of Sol J Barer’s form 4 insider trades.
Insider Ownership Summary of Sol J Barer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd | 2019-06-04 | director |
| AVTX | Avalo Therapeutics Inc | 2020-02-03 | director |
| CFRXQ | ContraFect Corp | 2017-07-25 | director |
 | | 2020-02-03 | director |
| | 2016-06-21 | director |
| | 2012-11-16 | director |
| | 2016-11-29 | director |
| | 2013-03-15 | director |
| | 2013-11-01 | director & 10 percent owner & Chairman of the Board |
| | 2023-07-05 | director |
Sol J Barer Latest Holdings Summary
Sol J Barer currently owns a total of 7 stocks. Among these stocks, Sol J Barer owns 1,506,946 shares of Celgene Corp (CELG) as of January 13, 2011, with a value of $163 Million and a weighting of 97.48%. Sol J Barer owns 220,442 shares of Teva Pharmaceutical Industries Ltd (TEVA) as of June 4, 2019, with a value of $3 Million and a weighting of 1.84%. Sol J Barer also owns 164,096 shares of NexImmune Inc (NEXI) as of March 30, 2023, with a value of $544,799 and a weighting of 0.33%. The other 4 stocks Amicus Therapeutics Inc (FOLD) , PDS Biotechnology Corp (PDSB) , ContraFect Corp (CFRXQ) , Aevi Genomic Medicine Inc (GNMX) have a combined weighting of 0.35% among all his current holdings.
Latest Holdings of Sol J Barer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2011-01-13 | 1,506,946 | 108.24 | 163,111,835 |
| TEVA | Teva Pharmaceutical Industries Ltd | 2019-06-04 | 220,442 | 13.98 | 3,081,779 |
| NEXI | NexImmune Inc | 2023-03-30 | 164,096 | 3.32 | 544,799 |
| FOLD | Amicus Therapeutics Inc | 2013-03-15 | 45,000 | 10.40 | 468,000 |
| PDSB | PDS Biotechnology Corp | 2015-10-06 | 32,277 | 3.82 | 123,298 |
| CFRXQ | ContraFect Corp | 2017-07-25 | 81,593 | 0.02 | 1,305 |
| GNMX | Aevi Genomic Medicine Inc | 2019-12-05 | 0 | 0.17 | 0 |
Holding Weightings of Sol J Barer
Sol J Barer Form 4 Trading Tracker
According to the SEC Form 4 filings, Sol J Barer has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 150,400 shares on January 13, 2011, which brought Sol J Barer around $4 Million.
According to the SEC Form 4 filings, Sol J Barer has made a total of 2 transactions in Teva Pharmaceutical Industries Ltd (TEVA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Teva Pharmaceutical Industries Ltd is the acquisition of 104,500 shares on June 4, 2019, which cost Sol J Barer around $1 Million.
According to the SEC Form 4 filings, Sol J Barer has made a total of 8 transactions in NexImmune Inc (NEXI) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in NexImmune Inc is the acquisition of 16,000 shares on March 30, 2023, which cost Sol J Barer around $164,000.
More details on Sol J Barer's insider transactions can be found in the Insider Trading History of Sol J Barer table.Insider Trading History of Sol J Barer
- 1
Sol J Barer Trading Performance
GuruFocus tracks the stock performance after each of Sol J Barer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sol J Barer is -16.17%. GuruFocus also compares Sol J Barer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sol J Barer within 3 months outperforms 3 times out of 18 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sol J Barer's insider trading performs compared to the benchmark.
Performance of Sol J Barer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.8 | | | | | |
| Relative Return to S&P 500(%) | -4.55 | | | | | |
Sol J Barer Ownership Network
Sol J Barer Owned Company Details
What does Teva Pharmaceutical Industries Ltd do?
Who are the key executives at Teva Pharmaceutical Industries Ltd?
Sol J Barer is the director of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include EVP & Chief Financial Officer Eliyahu Sharon Kalif , Exec. VP & European Commercial Richard Daniell , and See "Remarks" Vikki L Conway .
Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary
Over the past 18 months, Sol J Barer made no insider transaction in Teva Pharmaceutical Industries Ltd (TEVA). Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 281,251 shares made by Richard Daniell , a net sale of 223,026 shares made by Eric Drape , and a net sale of 137,076 shares made by Sven Dethlefs .
In summary, during the past 3 months, insiders sold 610,984 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 610,984 shares. During the past 18 months, 1,155,234 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,155,234 shares.
Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Teva Pharmaceutical Industries Ltd Insider Transactions
Sol J Barer Mailing Address
Above is the net worth, insider trading, and ownership report for Sol J Barer. You might contact Sol J Barer via mailing address: C/o Inspiremd, Inc., 321 Columbus Avenue, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
